Editorial Policy
Stroke and Vascular Neurology is an online-only, peer-reviewed, Open Access journal that aims to operate a fast submission and review process with continuous publication online, to ensure timely, up-to-date research is available worldwide. The Journal adheres to a rigorous and transparent peer-review process and all papers will be considered on the basis of ethical and methodological soundness rather than their novelty, significance, or relevance to any particular group.
Submissions should be made through the Journal’s online submission system. All submissions are subject to peer review. Articles should not have been published elsewhere or be under consideration by any other journal when submitted to Stroke and Vascular Neurology. This includes other journals published by BMJ.
Stroke and Vascular Neurology operates a single blind peer review, information on which can be found here. Peer review is managed by the editorial team rather than BMJ or the Chinese Stroke Association to ensure absolute editorial freedom of the journal.
Authors retain copyright of their work and articles are published under a Creative Commons licence.
General information about BMJ’s Open Access programme, including copyright policies and institutional memberships, is available via our author website.
Aims and Scope
Stroke and Vascular Neurology (SVN) is the official journal of the Chinese Stroke Association. Supported by a team of renowned Editors, and fully Open Access, the journal encourages debate on controversial techniques, issues on health policy and social medicine.
SVN will appeal to clinical stroke neurologists, neurosurgeons and basic neuroscientists. It will consider submissions of clinical and translational original research, short reports, editorials, and reviews to improve patient care.
Journal Statistics
|
Frequency |
Quarterly |
|
Acceptance rate |
83% (2016) |
|
Days to online publication |
15 days (2016) |
|
Launch date |
February 2016 |
|
Indexed by |
PubMed Central |
|
ISSN |
2059-8696 |
Affiliations
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organization of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.